ORKA Q3 2019 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$22,000

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-9.12

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$887,000

Free Cash Flow

-$889,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10M

Total Liabilities

$1M

Stockholders' Equity

$9M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$22,000	-$6,000	-266.7%
Operating Income	-$1M	-$2M	+25.0%
Net Income	-$1M	-$2M	+27.4%